These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10083098)

  • 1. Long-term follow-up of ABO-incompatible renal transplant recipients.
    Karakayali H; Moray G; Demirağ A; Turan M; Bilgin N; Haberal M
    Transplant Proc; 1999; 31(1-2):256-7. PubMed ID: 10083098
    [No Abstract]   [Full Text] [Related]  

  • 2. ABO-incompatible renal transplantation--dissociation of ABO antibodies.
    Uchida K; Tominaga Y; Haba T; Katayama A; Ichimori T; Yamada K; Hibi Y; Oikawa T; Takeda A; Morozumi K; Takagi H
    Transplant Proc; 1998 Aug; 30(5):2302-3. PubMed ID: 9723482
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation.
    Hadano T; Ohara T; Aikawa A; Hasegawa A
    Transplant Proc; 2000 Nov; 32(7):1847-9. PubMed ID: 11119966
    [No Abstract]   [Full Text] [Related]  

  • 4. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation.
    Gloor JM; Lager DJ; Fidler ME; Grande JP; Moore SB; Winters JL; Kremers WK; Stegall MD
    Transplantation; 2005 Dec; 80(11):1572-7. PubMed ID: 16371928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between ABO blood type antigen and antibody and acute vascular rejection in ABO incompatible kidney transplantation.
    Aikawa A; Hadano T; Ohara T; Hasegawa A; Yamashita M; Shindo M; Mizuiri T; Fushimi T; Sakai K; Hirayama N; Arai K; Tajima E
    Transplant Proc; 1998 Nov; 30(7):3507-9. PubMed ID: 9838538
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft survival rates in kidney transplant recipients of different blood groups.
    Haberal M; Demirağ A; Moray G; Karakayali H; Akkoç H; Turan M; Bilgin N
    Transplant Proc; 1998 May; 30(3):741-3. PubMed ID: 9595080
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of donor-specific skin graft is a reliable prognostic sign in ABO-incompatible live-donor renal transplants.
    Haberal M; Tokyay R; Bilgin N
    Transplant Proc; 1992 Dec; 24(6):2530-1. PubMed ID: 1465855
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tacrolimus in ABO-incompatible kidney transplantation: clinicopathological aspect of humoral rejection.
    Saito K; Nakagawa Y; Tanikawa T; Sonda K; Nishi S; Yamaguchi Y; Arakawa M; Takahashi K
    Transplant Proc; 1999 Nov; 31(7):2851-2. PubMed ID: 10578312
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The kidney transplantation from the ABO-incompatible donors].
    Goriaĭnov VA; Kaabak MM; Babenko NN; Shishlo LA; Morozova MM; Ragimov AA; Dashkova NG; Salimov ÉL
    Khirurgiia (Mosk); 2012; (7):70-4. PubMed ID: 22968508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
    Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation from spousal donors.
    Kikuchi K; Narumi Y; Hama K; Iwamoto H; Uchiyama M; Kozaki K; Degawa H; Matsuno N; Kozaki M; Nagao T
    Transplant Proc; 2000 Nov; 32(7):1817-8. PubMed ID: 11119951
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO-incompatible living-donor kidney transplantation in children.
    Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
    Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 16-year experience with 1275 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival.
    Park K; Kim YS; Kim MS; Kim SI; Oh CK; Han DS; Lee HY; Choi KH; Kim PK
    Transplant Proc; 1996 Jun; 28(3):1578-9. PubMed ID: 8658792
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
    Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
    Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.